Skip to main content
NCBI home page
Clinical Cardiology logoLink to Clinical Cardiology
. 2007 Jul 5;27(Suppl 2):4–11. doi: 10.1002/clc.4960271403

Epidemiology of transient ischemic attack and ischemic stroke in patients with underlying cardiovascular disease

Philip B Gorelick 1,✉
PMCID: PMC6654150  PMID: 15188931

Abstract

It is estimated that 15 to 30% of ischemic strokes are cardioembolic in origin, and that atrial fibrillation, valvular heart disease, coronary artery disease, congestive heart failure, and myocardial infarction are significant risk factors for stroke, which underscores the importance for cardiologists to understand this condition. The high incidence and substantial cost of stroke justify aggressive treatment of stroke risk factors, especially in the elderly, diabetic, and black populations, and in patients who have had an initial stroke. Antiplatelet therapy and administration of oral anticoagulants have both been shown to have a substantial impact on stroke in specified populations at risk.

Keywords: stroke, stroke risk factors, stroke epidemiology, cardiovascular disease, cerebrovascular event, antiplatelets

Full Text

The Full Text of this article is available as a PDF (64.1 KB).

References

  • 1. Sacco R: Current epidemiology of stroke. In Current Review of Cerebrovascular Disease (Eds. Fisher M, Bogousslavsky J.), p. 3–14. Philadelphia, Pa.: Current Medicine, 1993. [Google Scholar]
  • 2. Thorvaldsen P, Davidsen M, Bronnum‐Hansen H, Schroll M, for the Danish MONICA Study Group : Stable stroke occurrence despite incidence reduction in an aging population. Stroke trends in the Danish Monitoring Trends and Determinants in Cardiovascular Disease (MONICA) population. Stroke 1999; 30: 2529–2534 [DOI] [PubMed] [Google Scholar]
  • 3. Sacco RL: Risk factors, outcomes, and stroke subtypes for is‐chemic stroke. Neurology 1997; 49 (suppl 4): S39–S44 [DOI] [PubMed] [Google Scholar]
  • 4. American Stroke Association : Heart Disease and Stroke Statistics—2003 Update. Dallas, Texas, 2002. [Google Scholar]
  • 5. Sacco RL, Benjamin EJ, Broderick JP, Dyken M, Easton JD, Feinberg WM, Goldstein LB, Gorelick PB, Howard G, Kittner SJ, Manolio TA, Whisnant JP, Wolf PA: American Heart Association Prevention Conference IV:Prevention and rehabilitation of stroke. Risk factors. Stroke 1997; 28: 1507–1517 [DOI] [PubMed] [Google Scholar]
  • 6. National Stroke Association : The cost of stroke to all Americans. Available at: www.stroke.org/brain_stat.cfm. Accessed February 24, 2003.
  • 7. American Heart Association : Impact of stroke. Available at: www.strokeassociation.org/presenter.jhtm?identifier=1033. Accessed December 6, 2002.
  • 8. National Institute of Neurological Disorders and Stroke : National Institutes of Health. Questions and answers about stroke. Available at: www.ninds.nih.gov/health_and_medical/pubs/stroke_back‐grounder.htm. Accessed February 23, 2003.
  • 9. Brown RD, Petty GW, O'Fallon WM, Wiebers DO, Whisnant JP: Incidence of transient ischemic attack in Rochester, Minnesota, 1985‐1989. Stroke 1998; 29: 2109–2113 [DOI] [PubMed] [Google Scholar]
  • 10. American Heart Association : Strokes and “mini‐strokes” on the rise; totals may exceed 1.2 million. Available at: www.american‐heart.org/presenter.jhtml?identifier=2561. Accessed February 24, 2003.
  • 11. Albers GW, Caplan LR, Easton JD, Fayad PB, Mohr JP, Saver JL, Sherman DG, and the TIA Working Group : Transient ischemic attack—proposal for a new definition. N Engl J Med 2002; 347: 1713–1716 [DOI] [PubMed] [Google Scholar]
  • 12. Centers for Disease Control: Achievements in public health, 1900‐1999:Decline in deaths from heart disease and stroke—United States, 1900‐1999. MMWR 1999; 48: 649–656 [PubMed] [Google Scholar]
  • 13. Howard G, Howard VJ: Stroke incidence, mortality, and prevalence In The Prevention of Stroke (Eds. Gorelick PB, Alter M.), p. 1–10. New York, N.Y.: Parthenon Publishing Group, 2002. [Google Scholar]
  • 14. Vickrey BG, Rector TS, Wickstrom SL, Guzy PM, Sloss EM, Gorelick PB, Garber S, McCaffrey DF, Dake MD, Levin RA: Occurrence of secondary ischemic events among persons with atherosclerotic vascular disease. Stroke 2002; 33: 901–906 [DOI] [PubMed] [Google Scholar]
  • 15. Adams PF, Hendershot GE, Marano MA: Current estimates from the National Health Interview Survey, 1996. National Center for Health Statistics. Vital Health Stat 1999; 10: 200 [PubMed] [Google Scholar]
  • 16. Blackwell DL, Collins JG, Coles R: Summary health statistics for US adults:National Health Interview Survey, 1997. National Center for Health Statistics. Table 2. Percents (with standard errors) of selected circulatory diseases among persons 18 years of age and over, by selected characteristics:United States, 1997. Vital Health Stat 2002; 10 (205) [Google Scholar]; Available at: www.cdc.gov/nchs/data/series/sr_10/sr10_205.pdf
  • 17. Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO: Ischemic stroke subtypes:A population‐based study of incidence and risk factors. Stroke 1999; 30: 2513–2516 [DOI] [PubMed] [Google Scholar]
  • 18. Howard VJ, Howard G: “Nonmodifiable” risk factors for stroke:Age, race, sex, and geography In The Prevention of Stroke (Eds. Gorelick PB, Alter M.), p. 11–20. New York, N.Y.: Parthenon Publishing Group, 2002. [Google Scholar]
  • 19. American Heart Association : 2001 Heart and Stroke Statistical Update. Available at: 216.185.102.50/statistics/stroke.html. Accessed April 5, 2003.
  • 20. Woo D, Gebel J, Miller R, Kothari R, Brott T, Khoury J, Salisbury S, Shukla R, Pancioli A, Jauch E, Broderick J: Incidence rates of first‐ever ischemic stroke subtypes among blacks:A population‐based study. Stroke 1999; 30: 2517–2522 [DOI] [PubMed] [Google Scholar]
  • 21. Broderick JP, Brott T, Tomsick T, Huster G, Miller P: The risk of subarachnoid and intracerebral hemorrhages in blacks as compared with whites. N Engl J Med 1992; 326: 733–736 [DOI] [PubMed] [Google Scholar]
  • 22. Qureshi AI, Suri MAK, Safdar K, Ottenlips JR, Janssen RS, Frankel MR: Intracerebral hemorrhage in blacks. Risk factors, subtypes, and outcome. Stroke 1997; 28: 961–964 [DOI] [PubMed] [Google Scholar]
  • 23. Perry HM, Roccella EJ: Conference report on stroke mortality in the southeastern United States. Hypertension 1998; 31: 1206–1215 [DOI] [PubMed] [Google Scholar]
  • 24. Sacco RL, Boden‐Albala B, Abel G, Lin IF, Elkind M, Hauser WA, Paik MC, Shea S: Race‐ethnic disparities in the impact of stroke risk factors:The Northern Manhattan Stroke Study. Stroke 2001; 32: 1725–1731 [DOI] [PubMed] [Google Scholar]
  • 25. Sacco RL, Boden‐Albala B, Gan R, Chen X, Kargman DE, Shea S, Paik MC, Hauser WA: Stroke incidence among white, black, and Hispanic residents of an urban community:The Northern Manhattan Stroke Study. Am J Epidemiol 1998; 147: 259–268 [DOI] [PubMed] [Google Scholar]
  • 26. National Heart, Lung, and Blood Institute : Data Fact Sheet: The Stroke Belt:Stroke Mortality by Race and Sex. Hyattsville, Md.: National Institutes of Health, US Department of Health and Human Services, 1989. [Google Scholar]
  • 27. Hall WD, Ferrario CM, Moore MA, Hall JE, Flack JM, Cooper W, Simmons JD, Egan BM, Lackland DT, Perry M Jr, Roccella EJ: Hypertension‐related morbidity and mortality in the southeastern United States. Am J Med Sci 1997; 313: 195–209 [DOI] [PubMed] [Google Scholar]
  • 28. Wolf PA, Cobb JL, D'Agostino RB: Epidemiology of stroke In Stroke: Pathophysiology, Diagnosis, and Management, 2nd ed. (Eds. Barnett HJM, Mohr JP, Stein BM, Yatsu FM.), p. 8–27. New York, N.Y.: Churchill Livingstone, 1992. [Google Scholar]
  • 29. Helgason CM, Wolf PA: American Heart Association Prevention Conference IV: Prevention and Rehabilitation of Stroke. Circulation 1997; 96: 701–707 [DOI] [PubMed] [Google Scholar]
  • 30. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, Godwin J, Qizilbash N, Taylor JO, Hennekens CH: Blood pressure, stroke, and coronary heart disease. Part 2: Short‐term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827–838 [DOI] [PubMed] [Google Scholar]
  • 31. Joint National Committee : The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. J Am Med Assoc 2003; 289: 2560–2572 [DOI] [PubMed] [Google Scholar]
  • 32. National Center for Health Statistics : FASTATS. Hypertension. Available at: www.cdc.gov/nchs/fastats/hyprtens.htm. Accessed June 25, 2003.
  • 33. National Center for Health Statistics : Health, United States, 2002. Hyattsville, Md.: National Center for Health Statistics, 2002. [Google Scholar]
  • 34. Gorelick PB, Sacco RL, Smith DB, Alberts M, Mustone‐Alexander L, Rader D, Ross JL, Raps E, Ozer MN, Brass LM, Malone ME, Goldberg S, Booss J, Hanley DF, Toole JF, Greengold NL, Rhew DC: Prevention of a first stroke: A review of guidelines and a multidisciplinary consensus statement from the National Stroke Association. J Am Med Assoc 1999; 281: 1112–1120 [DOI] [PubMed] [Google Scholar]
  • 35. Goldstein LB, Adams R, Becker K, Furberg CD, Gorelick PB, Hademenos G, Hill M, Howard G, Howard VJ, Jacobs B, Levine SR, Mosca L, Sacco RL, Sherman DG, Wolf PA, del Zoppo GJ: Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation 2001; 103: 163–182 [DOI] [PubMed] [Google Scholar]
  • 36. Boden‐Albala B, Sacco RL: Modifiable risk factors for stroke: Hypertension, diabetes mellitus, lipids, tobacco use, physical inactivity, and alcohol In The Prevention of Stroke (Eds. Gorelick PB, Alter M.), p. 21–37. New York, N.Y.: Parthenon Publishing Group, 2002. [Google Scholar]
  • 37. Longstreth WT Jr, Nelson LM, Koepsell TD, van Belle G: Cigarette smoking, alcohol use, and subarachnoid hemorrhage. Stroke 1992; 23: 1242–1249 [DOI] [PubMed] [Google Scholar]
  • 38. Gill JS, Zezulka AV, Shipley MJ, Gill SK, Beevers DG: Stroke and alcohol consumption. N Engl J Med 1986; 315: 1041–1046 [DOI] [PubMed] [Google Scholar]
  • 39. Sacco RL, Elkind M, Boden‐Albala B, Lin IF, Kargman DE, Hauser WA, Shea S, Paik MC: The protective effect of moderate alcohol consumption on ischemic stroke. J Am Med Assoc 1999; 281: 53–60 [DOI] [PubMed] [Google Scholar]
  • 40. Thornton J, Symes C, Heaton K: Moderate alcohol intake reduces bile cholesterol saturation and raises HDL cholesterol. Lancet 1983; 2: 819–822 [DOI] [PubMed] [Google Scholar]
  • 41. Pelligrini N, Pareti FL, Stabile F, Brusamolino A, Simonetti P: Effects of moderate consumption of red wine on platelet aggregation and haemostatic variables in healthy volunteers. Eur J Clin Nutr 1996; 50: 209–213 [PubMed] [Google Scholar]
  • 42. Wolf PA: Cigarettes, alcohol, and stroke. N Engl J Med 1986; 315: 1087–1089 [DOI] [PubMed] [Google Scholar]
  • 43. Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO: Survival and recurrence after first cerebral infarction: A population‐based study in Rochester, Minnesota, 1975 through 1989. Neurology 1998; 50: 208–216 [DOI] [PubMed] [Google Scholar]
  • 44. Johnston SC, Gress DR, Browner WS, Sidney S: Short‐term prognosis after emergency department diagnosis of TIA. J Am Med Assoc 2000; 284: 2901–2906 [DOI] [PubMed] [Google Scholar]
  • 45. Streifler JY, Eliasziw M, Benavente OR, Harbison JW, Hachinski VC, Barnett HJ, Simard D: The risk of stroke in patients with first‐ever retinal vs. hemispheric transient ischemic attacks and high‐grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial. Arch Neurol 1995; 52: 246–249 [DOI] [PubMed] [Google Scholar]
  • 46. Straus SE, Majumdar SR, McAlister FA: New evidence for stroke prevention. J Am Med Assoc 2002; 288: 1388–1395 [DOI] [PubMed] [Google Scholar]
  • 47. Wolf PA, Abbott RD, Kannel WB: Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991; 22:983‐988 [DOI] [PubMed] [Google Scholar]
  • 48. Laupacis A, Albers G, Dalen J, Dunn MI, Jacobson AK, Singer DE: Antithrombotic therapy in atrial fibrillation. Chest 1998; 114 (5 suppl): 579S‐589S [DOI] [PubMed] [Google Scholar]
  • 49. Nadareishvili ZG, Rothwell PM, Beletsky V, Pagniello A, Norris JW: Long‐term risk of stroke and other vascular events in patients with asymptomatic carotid artery stenosis. Arch Neurol 2002; 59: 1162–1166 [DOI] [PubMed] [Google Scholar]
  • 50. Timsit SG, Sacco RL, Mohr JP, Foulkes MA, Tatemichi TK, Wolf PA, Price TR, Hier DB: Early clinical differentiation of cerebral infarction from severe atherosclerotic stenosis and cardioembolism. Stroke 1992; 23: 486–491 [DOI] [PubMed] [Google Scholar]
  • 51. North American Symptomatic Carotid Endarterectomy Trial Collaborators : Beneficial effect of carotid endarterectomy in symptomatic patients with high‐grade carotid stenosis. N Engl J Med 1991; 325: 445–453 [DOI] [PubMed] [Google Scholar]
  • 52. Gorelick PB: Stroke prevention therapy beyond antithrombotics: Unifying mechanisms in ischemic stroke pathogenesis and implications for therapy. An invited review. Stroke 2002; 33: 862–875 [DOI] [PubMed] [Google Scholar]
  • 53. DeGraba TJ: Inflammation, infection and homocysteine in atherosclerosis In The Prevention of Stroke (Eds. Gorelick PB, Alter M.), p. 49–64. New York, N.Y.: Parthenon Publishing Group, 2002. [Google Scholar]
  • 54. Melnick SL, Shahar E, Folsom AR, Grayston JT, Sorlie PD, Wang SP, Szklo M: Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Am J Med 1993; 95: 499–504 [DOI] [PubMed] [Google Scholar]
  • 55. Cook PJ, Honeybourne D, Lip GY, Beevers G, Wise R, Davies P: Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia: The West Birmingham Stroke Project. Stroke 1998; 29: 404–410 [DOI] [PubMed] [Google Scholar]
  • 56. Wimmer ML, Sandmann‐Strupp R, Saikku P, Haberl RL: Association of chlamydial infection with cerebrovascular disease. Stroke 1996; 27: 2207–2210 [DOI] [PubMed] [Google Scholar]
  • 57. Schneck MJ: Anticoagulation for stroke prevention In The Prevention of Stroke (Eds. Gorelick PB, Alter M.), p. 208–221. New York, N.Y.: Parthenon Publishing Group, 2002. [Google Scholar]
  • 58. Stamler J, Rose G, Stamler R, Elliott P, Dyer A, Marmot M: INTERSALT study findings: Public health and medical care implications. Hypertension 1989; 14: 570–577 [DOI] [PubMed] [Google Scholar]
  • 59. Abbott RD, Curb JD, Rodriguez BL, Sharp DS, Burchfield CM, Yano K: Effect of dietary calcium and milk consumption on risk of thromboembolic stroke in older middle‐aged men: The Honolulu Heart Program. Stroke 1996; 27: 813–818 [DOI] [PubMed] [Google Scholar]
  • 60. Mozaffarian D, Kumanyika SK, Lemaitre RN, Olson JL, Burke GL, Siscovick DS: Cereal, fruit, and vegetable fiber intake and the risk of cardiovascular disease in elderly individuals. J Am Med Assoc 2003; 289: 1659–1666 [DOI] [PubMed] [Google Scholar]
  • 61. Iso H, Jacobs DR Jr, Wentworth D, Neaton JD, Cohen JD, for the MRFIT Research Group : Serum cholesterol levels and six‐year mortality from stroke in 350,977 men screened for the Multiple Risk Factor Intervention Trial. N Engl J Med 1989; 320: 904–910 [DOI] [PubMed] [Google Scholar]
  • 62. Benfante R, Yano K, Hwang L‐J, Curb JD, Kagan A, Ross W: Elevated serum cholesterol is a risk factor for both coronary heart disease and thromboembolic stroke in Hawaiian Japanese men. Implications of shared risk. Stroke 1994; 25: 814–820 [DOI] [PubMed] [Google Scholar]
  • 63. Pradhan AD, Manson JE, Rossouw JE, Siscovick DS, Mouton CP, Rifai N, Wallace RB, Jackson RD, Pettinger MB, Ridker PM: Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: Prospective analysis from the Women's Health Initiative Observational Study. J Am Med Assoc 2002; 288; 980‐987 [DOI] [PubMed] [Google Scholar]
  • 64. Simon JA, Hsia J, Cauley JA, Richards C, Harris F, Fong J, Barrett‐Connor E, Hulley SB: Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen‐progestin Replacement Study (HERS). Circulation 2001; 103: 638–642 [DOI] [PubMed] [Google Scholar]
  • 65. CAPRIE Steering Committee : A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348: 1329–1339 [DOI] [PubMed] [Google Scholar]
  • 66. Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A: European Stroke Prevention Study 2: Dipyridamole and acetylsali‐cylic acid in the secondary prevention of stroke. J Neurol Sci 1996; 143: 1–13 [DOI] [PubMed] [Google Scholar]
  • 67. Gorelick PB, Richardson D, Kelly M, Ruland S, Hung E, Harris Y, Kittner S, Leurgans S, and the African American Antiplatelet Stroke Prevention Study Investigators : Aspirin and ticlopidine for prevention of recurrent stroke in black patients. J Am Med Assoc 2003; 289: 2947–2957 [DOI] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES